Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence
about
Prevention of recurrent stroke in patients with patent foramen ovaleModern management of a patent foramen ovaleAnticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis.In-hospital medical complications associated with stroke recurrence after initial ischemic stroke: A prospective cohort study from the China National Stroke RegistryThe risk of paradoxical embolism (RoPE) study: initial description of the completed databasePersonalized approach to primary and secondary prevention of ischemic strokePatent foramen ovale and closure technique with the amplatzer occluder.Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke."Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolismTranscatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials.Towards an epidemiology of the known unknowns in cryptogenic strokeRecurrent stroke on imaging and presumed paradoxical embolism: a cross-sectional analysisCryptogenic stroke in low-risk patients, consider a cardiac shunt at your peril.Percutaneous closure of patent foramen ovale: a near-perfect treatment ruined by careful study?Cost-effectiveness of transcatheter versus surgical management of structural heart disease.Comparison of Outcomes after Device Closure and Medication Alone in Patients with Patent Foramen Ovale and Cryptogenic Stroke in Korean PopulationRenal denervation: ultima ratio or standard in treatment-resistant hypertension.Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials.Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.Management of the stroke patient with patent foramen ovale: new insights and persistent questions in the wake of recent randomized trials.Cardioembolic stroke: practical considerations for patient risk management and secondary prevention.PFO and ASD Closure in Adulthood: Where Do We Stand?Evidence-based medical knowledge: the neglected role of expert opinion.Opportunities and challenges in using studies without a control group in comparative effectiveness reviews.The relationship of patent foramen ovale location with severity of stroke: A new risk factor for paradoxical embolism.Successful Percutaneous Transcatheter Patent Foramen Ovale Closure Through The Right Internal Jugular Vein Using Stiff Amplatzer Catheter With A Reshaped Tip.Role of occlusive devices to prevent thromboembolism among persons with a patent foramen ovale and prior stroke.Percutaneous closure of patent foramen ovale: "Closed" door after the last randomized trials?Recurrent episodic hypoxaemic respiratory failure following a strokeImpact of interatrial septum anatomic features on short- and long-term outcomes after transcatheter closure of patent foramen ovale: single device type versus anatomic-driven device selection strategy.Successful percutaneous transcatheter patent foramen ovale closure through the right internal jugular vein using a steerable catheter.Do we know, or do we believe?[Heart or brain? Problem patients at the interface between cardiology and neurology].Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry.Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack.Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.A Review of Transcatheter Closure of Patent Foramen Ovale.How to Understand Patent Foramen Ovale Clinical Significance - Part II: Therapeutic Strategies in Cryptogenic StrokeManagement of patent foramen ovale in patients with cryptogenic stroke: Is device closure superior to medical treatment? A brief review
P2860
Q27007029-60E0CACB-E49F-4E9F-B886-508C40758CABQ27025981-658CEDC2-959E-4710-91EB-ED6CE654AC72Q30978475-C56164C4-5CA6-4D12-8ED2-9650E12A7615Q33595494-AB81BB50-AA92-4FCE-993B-C7DAB08BDB84Q33768313-869F584D-889A-44B9-B156-CF4B03BA8A43Q33776783-062EA4D7-6D32-4D49-A16F-2B6350097DF0Q33904828-34990086-E1D2-4512-839E-251B42C193A2Q34591244-0B858A31-A191-4B09-9F0B-6B2F541B27C8Q34613373-60285998-E418-427A-8B03-1E9CBE4B9F59Q35065078-4E1BB0AD-4A2B-4D61-A2E4-471783D9729FQ35162638-B76CEAF8-564A-4FD0-B2B2-75EE988B74E2Q35846536-7975C5F0-399E-4EDE-A3C8-6FCFE2FADD21Q35976757-460F2606-E49D-4D16-8987-86B98DCF946FQ36079655-9CBCFF7B-6684-4952-94BD-994EE196CE2DQ36134563-9225482E-EE05-41DF-ADD6-E3DD85DFDCD4Q36707896-22380AC1-229B-4CC4-9494-E392412BAC0CQ36713381-9C9410FF-8019-4BFF-86ED-75C93A5CC7C9Q37291039-AC94FE2B-7707-4C45-A658-010A6FB6267EQ37603089-BE70B5C3-0A83-4C77-BE16-10F311787D8EQ38110188-3878F393-DFE1-4613-8E07-2DF7DC2652D4Q38176144-CFA64E58-6BA9-4F73-918B-98235AA4FF81Q38191511-AF075064-D84C-4CC7-95DB-286480BA0E73Q38255400-43F8018C-FE80-482B-94E0-DA15FE9E906EQ38520010-5C8C0EE0-989A-41A2-AA5D-E9BCD4BD1014Q40802106-94410670-5BB4-4304-A927-FF3D29631A69Q41110208-11204167-71E4-4252-A6C7-65CA66C9606FQ41284381-573613A2-D5C4-4CC3-8C90-E9648E145221Q41943558-59CFFDA7-FD8F-41E6-9358-697AC9EEA519Q42707250-6FAECC9A-E9FA-47D2-A047-38E7CD5AE548Q44526962-A2AD7FF9-0843-47EF-885A-D908D8424548Q45402906-C382DB6B-D875-442F-AFB4-AF088927CCF0Q45715214-A4F4040E-7E7F-41EC-8103-131F345B759EQ45939954-B3ABE66E-CACD-42DA-8CC9-389B2EF54F47Q47301561-9A7EDBDE-D771-4E6F-986F-C82F27160A41Q47678298-9B8BD90B-88EC-4025-991C-F7891FFBDA9EQ50662583-F76D1704-E6B6-40FC-8321-444459838F49Q53521301-3266DE4C-98B1-4120-B506-577315756E90Q55001530-B04289B0-32D3-4911-B914-16D4BF845A86Q57642050-E6958B86-B0F7-469D-B312-8E2636FB0EEAQ57652818-15C933E7-A815-49F4-9E23-886A3186E8F1
P2860
Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Patent foramen ovale closure a ...... tional and randomized evidence
@ast
Patent foramen ovale closure a ...... tional and randomized evidence
@en
Patent foramen ovale closure a ...... tional and randomized evidence
@nl
type
label
Patent foramen ovale closure a ...... tional and randomized evidence
@ast
Patent foramen ovale closure a ...... tional and randomized evidence
@en
Patent foramen ovale closure a ...... tional and randomized evidence
@nl
prefLabel
Patent foramen ovale closure a ...... tional and randomized evidence
@ast
Patent foramen ovale closure a ...... tional and randomized evidence
@en
Patent foramen ovale closure a ...... tional and randomized evidence
@nl
P2093
P2860
P31
P3181
P1433
P1476
Patent foramen ovale closure a ...... tional and randomized evidence
@en
P2093
A. M. Abu Dabrh
D. E. Thaler
D. M. Kent
G. D. Kitsios
I. J. Dahabreh
P2860
P304
P3181
P356
10.1161/STROKEAHA.111.631648
P407
P577
2012-02-01T00:00:00Z